Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the human factors/usability of Rheumatoid Arthritis (RA) patients with the
Metoject® prefilled pen (including a label comprehension assessment and a device robustness
evaluation).